Cellular pathology of atherosclerosis: Smooth muscle cells promote adhesion of platelets to cocultured endothelial cells

Circulation Research

Volumn 98, Issue 1, 2006, Pages 98-104

  Tull, Samantha P ^a   Anderson, Steve I ^a   Hughan, Sascha C ^a   Watson, Steve P ^a   Nash, Gerard B ^a   Rainger, G Ed ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Coculture; Endothelial cells; Platelet adhesion; Smooth muscle cells; Transforming growth factor 1

Indexed keywords

ANTIBODY; INTEGRIN ALPHA2B BETA3; PROSTACYCLIN; THEOPHYLLINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; FIBRINOGEN RECEPTOR; TGFB1 PROTEIN, HUMAN; THROMBIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CELL ADHESION; CELL CULTURE; CELL INTERACTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; SHEAR RATE; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; COCULTURE; CYTOLOGY; PATHOLOGY; PHYSIOLOGY; THROMBOCYTE ADHESIVENESS; VASCULAR SMOOTH MUSCLE;

ATHEROSCLEROSIS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VON WILLEBRAND FACTOR;

EID: 33644840620     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000198386.69355.87     Document Type: Article

References (68)

1. Ross R. Cell biology of atherosclerosis. Ann Rev Physiol. 1995;57: 791-804.
2. Fischer TM. Haemostasis: an overview. In: Pallister C, ed. Blood Physiology and Pathophysiology. 1st ed 1. Boston, Mass: Butterworth-Heineman; 1994: 447-472.
3. Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 1993;7: 516-522.
4. Rosenblum WI. Platelet adhesion and aggregation without endothelial cell denudation or exposure of basal lamina and/or collagen. J Vasc Res. 1997;34:409-417.
5. Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med. 1993;328:628-635.
6. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887-843.
7. Methia N, Andre P, Denis CV, Economopoulos M, Wagner DD. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001;98:1424-1428.
8. Radomski M, Palmer R Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;2:1057-1058.
9. Radomski MW, Palmer RM, Moncada S. Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol Sci. 1991;12:87-88.
10. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987;92:639-646.
11. Kaplan EJ, Moon DG, Weston LK, Minnear FL, Del Vecchio PJ, Shepard JM, Fenton JW. Platelets adhere to thrombin-treated endothelial cells in vitro. Am J Physiol. 1989;257:H423-H433.
12. Venturini CM, Weston LK, Kaplan JE. Platelet cGMP, but not cAMP, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium. Am J Physiol. 1992;263:H606-H612.
13. Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang JM, Shih CCY. Role pf platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke. 1996;27:709-711.
14. Radomski MW, Valance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res. 1993;27:1380-1382.
15. Shanberge JN, Kajiwara Y, Quattrociocchi-Longe T. Effect of aspirin and iloprost on adhesion of platelets to intact endothelium in vivo. J Lab Clin Med. 1995;125:96-101.
16. Gawaz M, Neumann FJ, Dickfeld T, Reininger A, Adelsberger H, Gebhardt A, Schomig A. Vitronectin receptor (αvβ3) mediates platelet adhesion to the luminal aspect of endothelial cells. Circulation. 1997;96: 1809-1818.
17. Reininger AJ, Korndorfer MA, Wurzinger LJ. Adhesion of ADP-activated platelets to intact endothelium under stagnation point in vitro is mediated by the integrin αIIbβ3. Thromb Haemost. 1998;79:998-1003.
18. Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1). αvβ3 integrin and GPIbα. J Ex Med. 1998;187: 329-339.
19. Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ. c7E3 Fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-adsorbed fibrinogen by blocking platelet GP IIb/IIIa as well as endothelial vitronectin receptor. Thromb Haemost. 2000;83: 217-223.
20. Kirton CM, Nash GB. Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J Lab Clin Med. 2000;136:303-313.
21. Tomita Y, Tanahashi N, Tomita M, Itoh Y, Yokoyama M, Takeda H, Schiszler I, Fukuuchi Y. Role of platelet glycoprotein IIb/IIIa in ADP-activated platelet adhesion to aortic endothelial cells in vitro. Clin Hemorheol Microcirc. 2001;24:1-9.
22. Varon D, Dardik R, Cattaneo M, Savion N. ADP promotes adhesion of resting platelets to endothelial cells under flow: the role of platelet and endothelial integrins. Blood. 2000;96:166.
23. Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Blood. 2000;96:3322-3328.
24. Huo YQ Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61-67.
25. Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: an interaction mediated by P-selectin. Proc Nat Acad Sci U S A. 1995;92:7450-7458.
26. Rainger GE, Wautier MP, Nash GB, Wautier JL. Prolonged E-selectin induction by monocytes potentiates the adhesion of flowing neutrophils to cultured endothelial cells. Br J Haematol. 1996;92:192-199.
27. Tsouknos A, Nash GB, Rainger GE. Monocytes initiate a cycle of leukocyte recruitment when cocultured with endothelial cells. Atherosclerosis. 2003;170:49-58.
28. Rainger GE, Nash GB. Cellular pathology of atherosclerosis. Smooth muscle cells prime cocultured endothelial cells for enhanced leukocyte adhesion. Circ Res. 2001;88:615-622.
29. Rainger GE, Stone P, Morland CM, Nash GB. A novel system for investigating the ability of smooth muscle cells and fibroblasts to regulate adhesion of flowing leukocytes to endothelial cells. J Immunol Methods. 2001;255:73-82.
30. Cooke BM, Usami S, Perry I, Nash GB. A simplified method for culture of endothelial cells and analysis of blood cells under conditions of flow. Microvasc Res. 1993;45:33-45.
31. Dong JF, Moake JL, Bernardo A, Areceneaux W, Shrimpton CN, Schade AJ, McIntyre LV, Fujikawa K, Lopez JA. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100:4033-4039.
32. Corjay MH, Thompson MM, Lynch KR Owens GK. Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle α-actin and nonmuscle β-actin mRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem. 1989;264:10501-10506.
33. Kanthou C, Kanse SM, Newman P, Kakkar VV, Benzakour O. Variability in the proliferative responsiveness of cultured human vascular smooth muscle cells to α-thrombin. Blood Coagul Fibrinolysis. 1995;6:753-760.
34. Benzakour O, Kanthou C, Newman P, Kakkar VV, Kanse SM. Long-term chemotaxis studies on adherent cells: effect of platelet-derived growth factor-BB on human vascular smooth muscle cell migration. Anal Biochem. 1995;230:215-223.
35. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.
36. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL. Adelsberger H, Langenbrink K, Page S, Neumeier D, Schomig A, Brand K. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 1998;98:1164-1171.
37. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin-1 synthesis. J Cell Biol. 2001;154:485-490.
38. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schomig A, Neumann FJ. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis. 2000;148:75-85.
39. Boehlen F, Clemetson KJ. Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice. Transfus Med. 2001;11:403-417.
40. Buttram SM, Hatten R, Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood. 1993;82:1165-1174.
41. Kuijper PH, Gallardo Torres HI, Houben LA, Lammers JW, Zwaginga JJ, Koenderman L. P-selectin and MAC-1 mediate monocyte rolling and adhesion to ECM-bound platelets under flow conditions. J Leuk Biol. 1998;64:467-473.
42. Sheikh S, Nash GB. Continuous activation and deactivation of integrin CD11b/CD18 during de novo expression enables rolling neutrophils to immobilize on platelets. Blood. 1996;87:5040-5050.
43. Rainger GE, Buckley C, Simmons DL, Nash GB. Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils. Curr Biol. 1997;7:316-325.
44. Stone PCW, Nash GB. Conditions under which immobilized platelets activate as well as capture flowing neutrophils. Br J Haematol. 1999;105:514-522.
45. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest and transmigration across activated, surface adherent platelets via sequential action of P-selectin and the β2 integrin CD11b/CD18. Blood. 1996;88:146-157.
46. Lalor P, Nash GB. Adhesion of leukocytes to immobilised platelets. Br J Haematol. 1995;89:725-732.
47. von Hundelshausen P, Weber KSC, Huo Y, Proudfoot AEI, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772-1777.
48. Lagadec P, Dejoux O, Ticchioni M, Cottrez F, Johansen M, Brown EJ, Bernard A. Involvement of CD47-dependent pathway in platelet adhesion on inflamed vascular endothelial cells under flow. Blood. 2003;101:4836-4843.
49. Bernardo A, Ball C, Nolasco L, Moake JF, Dong JF. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultra large von Willebrand factor multimers under flow. Blood. 2004;104:100-106.
50. Li JM, Podolsky RS, Rohrer MJ, Cutler BS, Massie MT, Barnard MR, Michelson AD. Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. J Surg Res. 1996;61:543-548.
51. Kojima H, Kanada H, Shimizu S, Kasama E, Shibuya K, Nakauchi H, Nagasawa T, Shibuya A. CD226 mediates platelet and megakaryocytic cell adhesion to vascular endothelial cells. J Biol Chem. 2003;278: 36748-36753.
52. Fressinaud E, Meyer D. Von Willebrand factor and platelet interactions with the vessel wall. Blood Coagul Fibrinolysis. 1991;2:333-340.
53. Padilla A, Moake JL, Bernardo A, Ball C, Wang Y, Arya M, Nolasco L, Trurner N, Berndt MC, Navari B, Lopez JA, Dong JF. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103:2150-2156.
54. Yap CL, Hughan SC, Cranmer SL, Nesbitt WS, Rooney MM, Giuliano S, Kulkarni S, Dopheide SM, Yuan Y, Salem HH, Jackson SP. Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin αIIbβ3. J Biol Chem. 2000;275:41377-41388.
55. Warwick S, Kulkarni S, Giuliano S, Goncalves I, Dopheide SM, Yap CL, Harper IS, Salem HH, Jackson SP. Distinct glycoprotein Ib/V/IX and integrin αIIbβ3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem. 2002;277:2965-2972.
56. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell. 1996;84:289-297.
57. Ku DN, Giddens DP. Pulsatile flow in a model carotid bifurcation. Arteriosclerosis. 1983;3:31-39.
58. Ku DN, Giddens DP, Zarins CK Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis. 1985;5:293-301.
59. Gamble JR, Vadas MA. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science. 1988;242:97-99.
60. Litwin M, Clark K, Noack L, Berndt M, Albelda S, Vadas M, Gamble J. Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J Cell Biol. 1997;139:219-228.
61. Gamble JR, Khew-Goodall Y, Vadas A. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J Immunol. 1993;150:4494-4503.
62. Chin YH, Ye MW, Cai JP, Xu XM. Differential regulation of tissue specific lymph node high endothelial venule cell adhesion by tumour necrosis factor and transforming growth factor-β1. Immunology. 1996;87:559-565.
63. Drake WT, Issekutz AC. Transforming growth factor-β1 enhances polymorphonuclear leucocyte accumulation in dermal inflammation and transendothelial migration by a priming action. Immunology. 1993;78: 197-204.
64. Kang YH, Brummel SE, Lee CH. Differential effects of transforming growth factor-beta 1 on lipopolysaccharide induction of endothelial adhesion molecules. Shock. 1996;6:118-125.
65. Dai JP, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P, Becquemin JP, Allaire E. Overexpression of transforming growth factor-beta 1 stabilizes already-formed aortic aneurysms. A first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112:1008-1015.
66. Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, Mezzetti A, Porreca E. Increased expression of transforming growth factor-beta 1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004;35:2253-2257.
67. Robertson AKL, Rudling M, Zhou XH, Gorellk L, Flavell RA, Hansson GK. Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J Clin Invest. 2003;112:1342-1350.
68. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res. 2001;89:930-934.